Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive Trial for Ebola Virus Disease Treatments
NCT02380625Phase 2Unknown
- Sponsor
- Clinical Research Management Group
- Start
- Apr 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of azithromycin, sunitinib, erlotinib, atorvastatin, irbesartan in Ebola virus disease (EVD), sponsored by Clinical Research Management Group. Status: unknown.
02
Drugs
azithromycinsunitiniberlotinibatorvastatinirbesartan
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on NCT02380625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02380625.